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1. Introduction  
Psoriasis, a chronic relapsing inflammatory skin disease with a disturbing global incidence 
of approximately 2%, is an afflicting and disfiguring skin disease with high morbidity 
(Lomholt, 1964). The disease is characterized by the well-demarcated erythematous plaques 
with silvery white scales and a predilection for body areas such as the elbows, knees, 
umbilicus and lumbar area (Schön & Boehncke, 2005). In contrast to normal skin, the dermal 
vasculature in psoriasis dermis is dramatically increased with large, tortuous blood vessels, 
accounting for the erythematous appearance or redness of the affected skin 
regions/psoriatic plaques (Nestle et al, 2009). In addition, the psoriatic epidermis is 
significantly thickened and acanthotic, due to hyperproliferative keratinocytes with an 
approximate seven-fold increase in the number of dividing cells in the basal and suprabasal 
epidermal layers (Castelijns et al, 2000). Keratinocytes of the psoriatic skin are prematurely 
differentiated, as evident in the incomplete cornification of the stratum corneum, 
characterized by the retention of nuclei (i.e., parakeratosis) and the loss of the granular 
layer. The stratum corneum of psoriasiform skin is also thickened (i.e., hyperkeratosis). This 
heavy disruption of epidermal differentiation and skin barrier homeostasis coupled with 
altered levels of intercellular adhesion molecules result in the widespread scaling of 
psoriatic lesions (Christensen et al, 2006). While psoriasis primarily affects the epidermis, the 
disease has a strong immunopathological basis, with the psoriatic skin being significantly 
infiltrated with immune cells. Notably, this immune infiltrate has a characteristic 
distribution and is composed mainly of dendritic cells and macrophages in the dermis, 
neutrophils in the epidermis and T cells in both layers. Another immunologic feature of the 
disease is its extracutaneous manifestation of an arthritic condition, which affects 
approximately 5% of the population and approximately 20% of psoriasis patients (Zachariae 
et al, 2002; Hueber & McInnes, 2007). However, the direct involvement of the skin and 
immune system in psoriasiform features complicates and confounds studies of psoriasis. 
Therefore, despite the detailed documented pathological observations of psoriasis and the 
vast research efforts aimed at understanding the disease, a key question remains 
unanswered: is psoriasis provoked by an epidermal or an immunological trigger?  
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2. Background 
It is well accepted that the pathology of psoriasis involves the participation of both the 
immune system and skin tissue; therefore a rational research approach would include 
studying the disease from an in vivo rather than an in vitro perspective. Hence, most 
psoriasis studies have been in the context of animal models which continue to serve as an 
invaluable platform for drug testing and development. While there is an absolute need for 
an in vivo platform, an ideal animal model is still lacking as no naturally and frequently 
occurring animal disease is known to exhibit every complex disease feature of psoriasis 
(Schön, 1999). Hence the study of psoriasis is narrowly limited to the artificial induction of 
the disease in laboratory animals. Nevertheless, several animal models have been developed 
in recent decades to meet the demands of psoriasis research. Study approaches include 
spontaneous mutants, T cell transfer models and xenografts.  
2.1 Spontaneous mutants 
The earliest psoriasis models were laboratory-bred mutant mice that were found to manifest 
skin lesions resembling psoriasis. These animals were spontaneous mutants of known allelic 
mutations. One such mutant strain was mice carrying the homozygous asebia mutation 
(Scd1ab/ Scd1ab). The skin of the asebia mouse is typified by hair loss (i.e., alopecia) and the 
complete absence of sebaceous glands. Like psoriatic human skin, asebia mouse skin 
displayed hyperkeratosis, epidermal acanthosis, increased dermal vascularity and an 
immune cell infiltrate (Gates & Karasek, 1965). However, unlike human psoriatic skin, the 
leukocytic infiltrate of asebia mouse skin was devoid of neutrophils and T cells. Because the 
immune system is strongly believed to account for a substantial portion of the pathogenesis 
of psoriasis, this difference in the inflammatory response in asebia mouse skin reduces the 
reliability of this disease model. Moreover, lipid metabolism in asebia mouse skin was 
significantly altered, implying a distinctly different disease mechanism from psoriasis, 
which further undermined its value as a psoriasis model (Wilkinson & Karasek, 1966). Two 
other homozygous mouse mutants, chronic proliferative dermatitis (cpd) and the flaky skin 
(fsn), also display a hyperproliferative epidermis, increased dermal vascularity and a mixed 
immune cell infiltrate including neutrophils in micro-abscesses of lesions. These similarities 
with human psoriatic skin make these animal models slightly superior to the asebia mouse 
model as disease models for psoriasis (Morita et al, 1995). However, the psoriasiform-like 
phenotype of both fsn and cpd critically lack a T cell-based immunopathogenesis. This was 
demonstrated by the ability of glucocorticosteroid treatment to improve the fsn lesions, 
which targets the innate immune response, but not with cyclosporine A, a licensed psoriasis 
drug which inhibits T cell-mediated immune responses (Sundberg et al, 1994). Cyclosporin 
A treatment also did not improve cpd skin lesions (HogenEsch et al, 1994). Fsn mice that 
were double homozygous for the severe combined immunodeficiency mutation (scid/scid) 
and lacked mature T and B lymphocytes also developed skin lesions nonetheless (Sundberg 
et al, 1994). Furthermore, the transfer of hemopoietic T cell precursors from cpd to syngeneic 
recipients did not pass on the psoriasiform condition (HogenEsch et al, 1994). Cpd and fsn 
are also far more complex than psoriasis; both involve pathologies that extend to other 
organ systems. This complexity confounds the study of psoriasis when these models are 
used. Critically, the psoriasiform-like phenotype of cpd and fsn could both develop without 
the participation of T cells, which are known key effectors in psoriasis (HogenEsch et al, 
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1994; Sundberg et al, 1994). Given these limitations, spontaneous mutants still fall short of 
being an ideal psoriasis model. The greatest concern about using this type of animal model 
for psoriasis research is that researchers are essentially deriving conclusions about the 
causes of psoriasis from diseases with another unknown basis. 
2.2 T cell transfer models 
The disqualification of the early animal models (i.e., fsn and cpd) as psoriatic models 
highlights the strong growing recognition of psoriasis as a T cell-mediated disease. Several 
clinical observations support this theory, including how psoriasis can be significantly 
improved with drugs targeting T cell-mediated immunity (Weinshenker et al, 1989). 
Streptococcal infection of the upper respiratory tract, which is remote from the skin, is 
known to trigger psoriasis via T cell-mediated responses to bacterial superantigens that 
mimic keratins. This process initiates a pseudo-autoimmune reaction responsible for the 
psoriasiform outcome (Prinz et al, 1991; Leung et al, 1995; Valdimarsson et al, 2009). 
Interestingly, psoriasis was shown to be transferrable when the bone marrow of an 
affected individual was transplanted into a previously unaffected recipient (Snowden & 
Heaton, 1997). Conversely, psoriasis in a previously affected individual was completely 
cured after bone marrow ablation prior to transplant (Eedy et al, 1990). While phagocytic 
immune cells (i.e., neutrophils, macrophage and dendritic cells) are responsible for 
indiscriminate immune functions such as the engulfment of pathogens or cellular debris 
and antigen presentation (Delves & Roitt, 2000), T cells have a more specific molecular 
recognition role in the immune system. In summary, every cytotoxic CD8 T cell clone 
possesses antigen specificity, allowing it to recognize a unique antigen presented on the 
major histocompatibility complex (MHC) of non-immune cells. For example, this antigen 
could be a viral peptide in the context of an infected cell, a foreign peptide in the context 
of an allograft, or a self peptide in the event of an autoimmune response. In any of these 
cases, CD8 T cells would mount a cytotoxic response against the target cell. The CD8 T 
cells can mediate a necrotic cell killing through the targeted secretion of lytic proteins, 
perforin and granzyme, onto the target cells. These proteins drastically destabilize the 
target cell membrane, eventually leading to osmotic stress and colloid osmotic lysis 
(Delves & Roitt, 2000).  
The classic study of tissue graft rejection showed that the adoptive transfer of normal T cells 
into nude mice scid would lead to an immune rejection of the host animal’s skin (Roopenian 
& Anderson, 1988). An experimental proof of T cell pathogenesis for psoriasis would require 
a T cell-mediated response directed against skin cells. Using principles of tissue graft 
rejection, MHC compatible naïve CD4+/CD45RBHi T lymphocytes that were minor 
histocompatibility complex mismatched were transplanted into scid/scid mice. The minor 
histocompatibility mismatch was aimed at minimizing the severity of the immune response 
and hence prolonging the rejection process. Without fail, this procedure led to the 
development of clinically consistent psoriasiform skin within 4-8 weeks. The resulting 
mouse skin lesions were markedly similar to those of human psoriatic skin; they shared the 
key histopathological features of acanthosis, parakeratosis, leukocytic infiltrate and dermal 
angiogenesis. Remarkably, pro-inflammatory cytokine expression in the lesional skin was 
also similar to that of human psoriatic skin, with elevated expressions of tumor necrosis 
factor-┙ (TNF-┙), interleukin-6 (IL-6), interferon-┛ and granulocyte macrophage colony 
stimulating factor (GM-CSF). These lesions also responded well to immunosuppressive 
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treatments such as cyclosporine A and ultraviolet B (310 nm) phototherapy (Schön et al, 
1997). Taken together, these features suggest that an epidermal abnormality is unnecessary 
for the formation of psoriatic lesions and that a T cell-invoked immune response results in 
psoriasiform skin. However, this model cannot rule out the involvement of an epidermal 
trigger, as T cells were deliberately mismatched to the host skin cells. Hence, this T cell 
transfer model can only be used to study cutaneous psoriatic events post-T cell activation 
and not those processes preceding T cell activation.  
2.3 Xenografts 
Although animal and T cell transfer models offer a convenient bench approach to studying 
psoriasis, they still do not reflect the genuine pathogenesis of the disease. Animal models 
may have typical psoriasiform-like skin lesions but closer analysis has revealed critical 
cellular differences from the human disease. In addition, T cell transfer models exhibit only 
the immune aspects of psoriasis after T cell activation, and they lack all aspects of the 
preliminary events leading to T cell activation. Furthermore, the vast differences between 
mouse and human skin further complicate the ability to extrapolate animal models to the 
actual human disease (Gudjonsson et al, 2007). Hence, another approach is to study every in 
situ event of human psoriatic skin in vivo. This has been made possible by 
xenotransplantation, whereby human diseased skin is grafted across species to an 
immunocompromised murine host. With xenotransplantation, psoriatic features of diseased 
human skin can be maintained for more than 2 months, providing sufficient study time 
(Krueger et al, 1975). Apart from T cells originating in the systemic circulation, resident T 
cells and other immune cells in psoriatic skin may also contribute to pathogenesis, which is 
not possible using T cell models.  Xenotransplantation models circumvent this shortcoming, 
as all forms of resident immune cells in the transplanted diseased skin may be continually 
studied post-transplantation (Boehncke & Schön, 2007). Altogether, xenotransplantation 
models allow the study of in situ events in the context of actual human psoriatic skin. This 
approach has helped elucidate the role of resident T cells in disease pathogenesis and 
helped identify the molecules involved in the epidermal recruitment of T cells, such as 
integrin ┙1┚1 (Conrad et al, 2007). Importantly, the xenotransplantation method allows for 
comparisons between involved and uninvolved skin (Boehncke et al, 1994; Nickoloff et al, 
1995). Xenotransplantation models may also be used to study other components of the 
immune system, such as the role of natural killer cells in psoriasis. The immune background 
of the host could be modified by cross-breeding mouse strains that carry mutations to 
different immunity-related genes. For example, non-obese diabetic (NOD) mice with 
impaired natural killer and antigen presenting cells could be combined with scid through 
cross-breeding to generate a host animal with a modified immune background to enhance 
the study of natural killer cells in psoriasis (Roder & Duwe, 1979;  Shultz et al, 1995). With 
this concept, many other combinations of immune backgrounds have since been innovated 
to support novel studies. Regarding drug discovery studies, xenotransplantation models 
facilitate the testing of human directed antibodies or biologics because of the limited cross-
species reactivity (Boehncke, 2005). However, xenotransplantation models do have their 
own shortcomings and limitations, including the challenge of assessing T cell homing 
processes since human T cells in the transplanted xenograft may not transit normally to 
mouse lymph nodes in the hybrid natured “two-species-systems” (Garcia et al, 1997).  Also, 
xenotransplantation is limited by a lack of diseased skin donors. In response to this issue, a 
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bioengineered skin-humanized mouse model was recently developed. Healthy human skin 
biopsies were engrafted onto mice and allowed to regenerate. T cells isolated from blood 
samples of the same donors were cultured in vitro and transfected with recombinant IL-17 
and IL-22 expression vectors. The regenerated skin graft was then reconstituted with this T 
cell population through intradermal injections. The stratum corneum surface of the graft 
was also removed by mild abrasion, which then triggered psoriasiform features. The 
bioengineered skin was claimed to accurately represent human psoriatic skin (Guerrero-
Aspizua et al, 2010).  
2.4 Transgenic animal models 
With the advent of genetic engineering, another approach using transgenic expression of 
individual molecules in the mouse epidermis has allowed scientists to identify possible 
psoriatic triggers. To assess the relevance of a protein factor, researchers induce an 
overexpression of the factor in the epidermis. By varying the promoter used, scientists can 
localize and target the epidermal overexpression to either the basal or the suprabasal layer, 
taking advantage of distinct promoters found in the different skin layers. For example, there 
is exclusive expression of keratin 14 in the basal layer and involucrin in the suprabasal 
keratinocytes. Epidermal overexpression helps enhance the presence of the protein of 
interest in the skin which enables investigations of the effects of the proteins on the immune 
system (Schön, 2008). To date, most of the proteins shortlisted for studies are related to the 
immune system or angiogenesis (e.g., TNF-┙, IL-1┙, IL-6, IL-8, IFN-┛, ICAM-1, VEGF, etc.). 
Comparatively few proteins studied are of epidermal origin (i.e., TGF-┙, KGF, etc.) because 
previous studies using animal or T cell transfer models have identified a more 
immunological etiology of psoriasis (Schön, 1999). While the compilation of these studies 
suggests a strong immunopathogenic basis for psoriasis, an epidermal trigger of psoriasis 
cannot be completely discounted, as these in vivo disease models also involve the immune 
and cutaneous systems of animal models. 
3. New players in psoriasis identified from wound repair studies 
While the current evidence suggests that dysregulation of the immune system, particularly 
abnormal Th1 and Th17 immune responses, is the primary and predominant pathogenic 
basis for psoriasis, it is still debatable how epidermal barrier dysfunction contributes as a 
primary and secondary etiological factor in psoriasis. It is noteworthy that psoriasis 
susceptibility has been linked to a large number of genes, including those involving 
epidermal and immunological functions. While psoriasis has been associated with key 
adaptive immune genes like the PSORS1 MHC locus antigen cluster (Allen et al, 2005), it has 
also been linked to epidermal proteins like the S100 proteins (Wolf et al, 2010). These genetic 
associations reinforce the mechanistic complexity of psoriasis, which cannot be reduced 
simply to either an epidermal or immunological mode of causation. This uneven balance of 
research attention could also stem from the natural difficulty of studying cutaneous factors 
in animal models. While immune cells can be studied by their transfer into an in vivo system, 
the same cannot be said for keratinocytes. Moreover, immune responses are always obligate 
and inseparable from the in vivo context of an animal model. Skin grafting, for example, 
inevitably leads to wounding and subsequent inflammation in the grafted skin region. In 
every study performed on an animal host, immune responses are inevitable after 
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manipulation or perturbation of the epidermal barrier. The heavy influx of immune 
responses and their corresponding mediators would obscure any genuine causal triggers, 
especially if the cause may be of a subtle epidermal origin. A similar obfuscation of 
epidermal causes could happen in the actual human disease, confounding the continual 
search for an initiating factor. Moreover, the concept of skin as a immunological tissue has 
gradually gained importance over the last two decades, supported by the notion of skin-
associated lymphoid tissue (SALT) that was conceptualized in the early eighties. This SALT 
concept supports a specialized exclusive circulation of immune cells between the skin, the 
draining lymph nodes and the systemic circulation, which facilitates the priming of the T 
cell-mediated response in the skin (Streilein, 1983; Streilein, 1989). This helps highlight the 
importance of the adaptive immune response in psoriasis. Furthermore, to effectively 
safeguard the extensive cutaneous barrier against the external environment, 
immunosurveillance of the skin cannot rely solely on skin-residing immune scavenger cells 
(i.e., Langerhans cell). Rather, the average keratinocyte can capably assume the versatile role 
of an immune sentinel in the epidermis (Nestle et al, 2009). Armed with Toll-like receptors 
(TLRs) on their surfaces, keratinocytes recognize pathogen-associated molecular patterns on 
invading microorganisms and activate both cell-mediated immune responses and the 
production of type I interferons (IFNs) (Baker et al, 2003; Mempel et al, 2003; Pivarcsi et al, 
2004). Keratinocytes are also constitutive producers of pro-inflammatory cytokines (i.e., IL-1, 
TNF-┙, IL-6, IL-10, etc.) (Pivarcsi et al, 2004; Nestle et al, 2009) and can express MHC class II 
molecules (Nickoloff & Turka, 1994). It is thus feasible for keratinocytes to serve as adjunct 
antigen-presenting cells (Nickoloff & Turka, 1994). As such, the keratinocyte, despite being a 
non immune cell, can trigger both the innate and adaptive immune responses, suggesting 
that it can act as a peripheral extension of the immune system. Importantly, the role of 
epidermal barrier dysfunction in psoriasis should not be overlooked given the inextricable 
relationship between the skin and the immune system.  
3.1 A neglected aspect of psoriasis research: The relevance of wound healing 
3.1.1 Koebner phenomenon 
Although psoriasis is strongly believed to have an underlying genetic predisposition, 
psoriatic plaque formation is demarcated and usually does not cover or affect the patient’s 
entire skin area (Schön & Boehncke, 2005). The unexpected outbreak of psoriatic lesions in 
most patients gives the impression of an unpredictable skin condition and has greatly 
complicated the study of psoriasis. With an unknown trigger for psoriasis, it is difficult to 
rationally attribute a direct or indirect causation to either the epidermal or the immune 
systems. Thus, to understand the epidermal role in psoriasis, it is advantageous to trigger 
psoriatic plaque formation on uninvolved skin with a specific epidermal perturbation and 
subsequently study the molecular changes in keratinocytes corresponding to the known 
perturbation. This is, however, impossible in animal models in which psoriasis does not 
naturally occur (Schön, 1999). 
The Koebner phenomenon is a well recognized clinical finding in psoriasis, whereby new 
psoriastic lesions can be induced in previously uninvolved skin after skin wounding or 
trauma. Such psoriatic lesions usually form within 10-20 days of the wounding event, 
coinciding with the duration of the wound healing phase. This strongly suggests that skin in 
predisposed individuals may still develop normally until substantial triggering by key 
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epidermal perturbations (Weiss et al, 2002). Wounding stands out as the only known 
epidermal perturbation with the predictable ability to trigger psoriasis, thus offering a 
unique opportunity to study pathogenetic mechanisms in psoriasis. While the molecular 
basis for koebnerized psoriasis remains largely unexamined (Weiss et al, 2002), wound 
healing studies have been comparatively well established. Considering the obligate 
coincidence and connection between wounding and psoriasis, an adequate understanding of 
koebnerized psoriasis requires a solid understanding of wound healing. The Koebner 
phenomenon was initially described after animal bite wounds and incision wounds. 
However, with accumulated observation and documentation, the Koebner phenomenon 
was later broadened to more accurately and extensively include psoriasis arising from all 
other forms of skin injury such as insect bites, friction, pressure wounds, excoriations, burns, 
contact dermatitis, chemical irritation, infections, tattoo and sunburns (Sagi & Trau, 2011). 
Some interesting exceptions were also made and accordingly, not every form of trauma 
resulted in koebnerization. Some interesting exceptions have been observed that did not 
result in koebnerization, such as experimentally inflicted knife blade injury to the dermis 
that did not produce psoriatic lesions on the overlying epidermis above the wounded 
dermal portion, but only at the incisional point where the epidermis was damaged (Farber 
et al, 1965). Likewise, the dermal injection of potent inflammatory stimulators like 
hyaluronidase and chymotrypsin did not initiate a Koebner response (Farber et al, 1965). 
The key conclusion from both experiments was that koebnerization must involve epidermal 
traumatic damage (Farber et al, 1965). This finding was further confirmed by suction 
blistering experiments, resulting in epidermal and dermal separation without epidermal 
rupture, which did not induce koebnerization (Miller, 1982; Pedace et al, 1969). The criterion 
of an epidermal rupture needed for koebnerization is crucial and on a microscopic level, 
necrotic damage of keratinocytes will activate the innate inflammatory cascade leading to 
psoriasis (Chen et al, 2007). Thus, it is conceivable that some forms of wounds, perturbations 
and traumas to the skin are not as visibly obvious as others. These subtle forms of epidermal 
injuries could lead to koebnerized psoriasis but still display the misleading outward 
appearance and impression of a spontaneous psoriatic outbreak. This revelation will shed 
light on many of our clinical and scientific observations concerning psoriasis. As mentioned 
earlier, adoptive T cell transfer experiments in scid mice have demonstrated the independent 
ability of T cells to promote the complex pathogenesis of psoriasis (Schön et al, 1997). It is 
likely that transplanted minor histocompatibility complex mismatched T cells would direct 
a T cell-mediated cytotoxic response against host keratinocyte cells leading to widespread 
necrotic epidermal damage, hence fueling the onset of koebnerized psoriasis. Furthermore, 
the injured epidermis may expose putative self antigens to the adaptive immune system, 
triggering an autoimmune inflammatory reaction. The importance of undetected, insidious 
micro-trauma to the skin as a possible initiating and aggravating factor in psoriasis cannot 
be over-emphasized and may explain the predilection for psoriasis over sites of frequent 
trauma such as the knees and elbows (Schön & Boehncke, 2005).  Recent advances in wound 
healing research has enhanced our understanding and allowed better insight into the role of 
wound healing in the pathogenesis of psoriasis.  
3.2 Events in wounding 
Wounding or skin injury results in keratinocyte disruption leading to an epidermal gap that 
may expose the dermis if sufficiently large or deep. With the epidermal barrier being the key 
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protective barrier against various insults of the external environment, re-epithelialization of 
the breached epidermis is an urgent priority to close the wound gap and restore epidermal 
integrity. Keratinocytes at the edge of the wound are required to proliferate and migrate to 
fill up the epidermal gap to effectively seal it (Stadelmann et al, 1998).  
The wound and psoriatic lesional microenvironment in the initial stages appear to be largely 
similar in terms of the abundant production of pro-inflammatory cytokines, such as TNF-┙, 
IFN-┛ and IL-1 (Nickoloff et al, 2006). Keratinocytes in wound sites and psoriatic lesions are 
also similarly differentiated; both express keratin 6 (K6), keratin 16 (K16) and keratin 17 
(K17) instead of the standard keratin 1 (K1) and keratin 10 (K10) expressed by normal 
differentiating suprabasal keratinocytes (de Jong et al, 1991; Mommers et al, 2000; Wang & 
Chang, 2003). This suggests that transcriptional regulation responsible for both wound 
healing and psoriasis are similar. It is thus relevant to identify the key transcriptional 
regulators responsible for wound healing to evaluate its impact on psoriatic skin. 
3.3 Nuclear hormone receptors as prospective transcriptional regulators in wounded 
skin 
Among transcriptional regulators, nuclear hormone receptors are of particular interest. 
Nuclear hormone receptors (NRs), such as the retinoid acid receptors, are  one of the largest 
known classes of transcription factors, several have significant transcriptional activities in 
the skin and are responsible for skin homeostasis (Redfern & Todd, 1992). In humans, this 
superfamily comprises 48 ligand-dependent or “orphan” transcription factors (Robinson-
Rechavi et al, 2003). Unlike conventional transmembrane receptors, NRs are intracellular 
and locked in an inactive conformation by means of a bound chaperone (i.e., heat shock 
proteins, immunophilins) (Young & Hartl, 2002). Upon ligand binding in the cytosol, the 
chaperone is displaced, and the nuclear receptor is freed to undergo an active conformation, 
enabling its translocation into the nucleus where it subsequently binds specific DNA 
recognition elements present in the promoter sequence of target genes, inducing their 
transcription (Gronemeyer et al, 2004). As such, NRs are dual functional, serving as both a 
receptor and a transcription factor. The active conformation of NRs possesses a hydrophobic 
pocket as the ligand-binding site (Gronemeyer et al, 2004). Hence, ligands of NRs are 
necessarily small hydrophobic molecules (e.g., fatty acids, steroid hormones, thyroid 
hormones, vitamin D, retinoids, etc.), which eases their diffusion-based passage through the 
hydrophobic cell membrane and their subsequent binding to intracellular receptors 
(Friedmann et al, 2005). Furthermore, the skin is increasingly recognized as an endocrine 
tissue because it synthesizes and modifies steroidal hormones, which subsequently has 
autocrine, paracrine or endocrine signaling functions (Zouboulis, 2009). As such, significant 
research attention has been paid to NRs and their transcriptional regulatory role in the skin. 
Agonist and antagonist drugs that target the NR family constitute one of the largest and 
most potent groups of pharmaceuticals currently in use, and thus hold great potential for 
use in improved wound treatment strategies (Sladek, 2003). 
3.3.1 PPAR as wound healing transcription regulator and psoriasis trigger 
Recent research by various groups including our laboratory has highlighted the crucial role 
of a distinct member group of the NR superfamily, the peroxisome proliferator-activated 
receptors (PPARs), in wound healing (Tan et al, 2004). PPARs consist of three isotypes, 
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namely ┙, ┚/├ and ┛ (Tan et al, 2004). Specifically, studies of adult murine skin wounds 
have shown that wounding rapidly elevates the expression of PPAR ┚/├ from an initially 
undetectable range to very high levels in wound-edge keratinocytes located at the 
interfollicular regions of the epidermis (Tan et al, 2004). Apart from the epidermis, dermal 
PPAR ┚/├ levels were also up-regulated (Tan et al, 2004). In addition to wounding, the up-
regulation of PPAR ┚/├ in interfollicular keratinocytes was also observed upon hair 
plucking and treatment with chemical irritants like phorbol esters, which can induce skin 
inflammation, epidermal hyperplasia and act as tumor promoting agents (TPAs) 
(Fürstenberger et al, 1981; Tan et al, 2003). The common underlying theme of these three 
skin perturbation events is that they all involve a preliminary phase of inflammation 
followed by epidermal proliferation. Wounding and hair plucking which are examples of 
koebnerization, both involve damage to the epidermis that initiate inflammation, followed 
by keratinocyte proliferation in order to re-epithelialize the breached epidermis. 
Inflammation and a hyperproliferative epidermis are also hallmark features of psoriasis, 
thus suggesting the possible involvement of PPAR ┚/├ in the transcription regulatory 
process of psoriasis. We conducted in vitro studies on mouse primary keratinocytes to 
evaluate the means of PPAR ┚/├ up-regulation during wounding. A mixed leukocyte 
reactions (MLR) procedure was used to mimic the inflammatory environment in the wound. 
MLR involves exposing immature bone marrow-derived dendritic cells (DCs) and T cells to 
a necrotic cellular mixture of minced skin. DCs activated by the necrotic cellular mixture 
will induce T cells to synergistically produce pro-inflammatory cytokines equivalent to 
those produced in a wound environment (i.e., TNF-┙, IFN-┛, IL-1, etc.). Incubation of 
keratinocytes with the conditioned MLR media led to the up-regulation of PPAR ┚/├. In 
fact, TNF-┙ and IFN-┛ were confirmed to be the signaling inducers responsible for this 
PPAR ┚/├ up-regulation. TNF-┙ and IFN-┛ were also found to up-regulate the endogenous 
ligand of PPAR ┚/├, hence enhancing the transcriptional activity of PPAR ┚/├ in the 
wounded skin. Without this production of the ligand, transcription through PPAR ┚/├ 
would have been futile despite a deliberate overexpression of PPAR ┚/├ (Tan et al, 2001). 
In summary, wounding and skin injury lead to epidermal damage, which trigger innate skin 
inflammation. Excessive pro-inflammatory cytokines in the inflamed skin induce the up-
regulation of PPAR ┚/├ and its endogenous ligand, which subsequently counter the 
apoptotic consequences of inflammation, favoring epidermal hyperproliferation (Tan et al, 
2001). This relationship was first established in wounding studies and bears clear 
resemblances to the pathological manifestation of psoriasis. This insight into PPAR ┚/├’s 
involvement in wound healing prompted further investigation into its probable role in 
psoriasis. Immunohistochemistry and expression profiling studies have revealed that PPAR 
┚/├ is overexpressed in the psoriatic lesions of most patients (Romanowska et al, 2010). The 
overexpression of PPAR ┚/├ in mouse skin also resulted in an inflammatory skin disease 
that was phenotypically similar to psoriasis (Romanowska et al, 2010). 
Other epidermal factors have also been linked to psoriasis. One emerging area of interest is 
the S100 proteins, a multigene family of low molecular weight calcium binding proteins 
encoded within a well known psoriasis susceptibility locus (PSOR4) on chromosome 1q21 
(Semprini et al, 2002). S100A7 (psoriasin) and S100A15 (koebnerisin), prominent members of 
this protein family, are up-regulated in skin inflammation and psoriasis (Semprini et al, 
2002). Uninvolved psoriatic skin was found to have more constitutively enhanced 
S100A7/A15 expression than healthy skin (Wolf et al, 2010). In lesional psoriatic skin, the 
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level of S100A7/A15 was further elevated, suggesting its significant role in the disease. This 
up-regulated S100A7/A15 expression was also retained when psoriatic keratinocytes were 
isolated and cultured in vitro (Wolf et al, 2010). S100A7/A15 was found to prime psoriatic 
keratinocytes, thereby increasing their susceptibility to inflammation (Wolf et al, 2010). This 
has been largely attributed to its autocrine effect on keratinocytes with recent studies 
confirming the intracellular presence of S100A7 (Broome et al, 2003). Moreover, S100A7 
expression was also correlated with epidermal fatty acid binding protein (E-FABP), a 
keratinocyte protein that is distinctly up-regulated in psoriasis (Ruse et al, 2003). As it is 
difficult for lipophilic ligands to traverse through the hydrophilic cytosolic environment 
enroute the nucleus,  E-FABP eases this transition by binding the endogenous ligands and 
transferring them to the PPAR ┚/├ receptor (Kannan-Thulasiraman et al, 2010). Notably, 
S100A7 has been found to bind and co-localize with E-FABP in keratinocytes (Broome et al, 
2003). This interaction effectually stabilizes intracellular E-FABP levels (Broome et al, 2003).  
Hence, E-FABP is necessary for PPAR ┚/├ to stabilize and function effectively as a nuclear 
receptor (Kannan-Thulasiraman et al, 2010). This relationship explains how increased levels 
of S100A7 predisposes keratinocytes to inflammation and psoriasis, possibly via the 
stabilization of PPAR ┚/├ receptors for their relevant transcriptional activity. As S100 
proteins interact with their target proteins in a calcium-dependent manner, it is also possible 
that calcium released from the endoplasmic reticulum during inflammation activates 
S100A7 which acts together with PPAR ┚/├ to induce transcription of anti-apoptotic 
features in psoriatic keratinocytes. Herein, the role of PPAR ┚/├ in psoriasis is reinforced. 
3.4 ROS-induced oxidative damage of keratinocytes as initiating event of psoriasis 
Psoriatic lesions are associated with up-regulated levels of reactive oxygen species (ROS) 
(Zhou et al, 2009). Using dichlorodihydrofluorescein diacetate (DCF) staining, we assessed 
levels of intracellular ROS in mouse wounds and found ROS levels in wound epithelial 
tissue peaking at 3-7 days post-injury (Lam et al, 2011). This ROS up-regulation is likely 
secondary to the strong pro-inflammatory wound microenvironment, supported by TNF-┙, 
which can up-regulate cellular ROS (Kim et al, 2010). ROS-induced oxidative damage can 
trigger both apoptotic and necrotic cell death through multiple mechanisms including DNA 
fragmentation (Higuchi, 2003) and mitochondria cytochrome c release (Kirkland & Franklin, 
2001). While all previously mentioned forms of skin trauma involve external perturbation to 
the epidermis, this endogenous ROS-triggered necrotic cell death secondary to epidermal 
trauma may theoretically be the initializing cause of koebnerized psoriasis. Such an ROS-
triggered skin trauma could arise in apparently unwounded psoriatic skin based on 
intracellular signaling dysregulation and could help explain the spontaneous occurrence of 
psoriatic lesions. However, key questions remain as to how this death-promoting ROS 
signal is regulated.   
Interestingly, we have found that the wound expression of transforming growth factor-┚ 
(TGF-┚) activated kinase 1 (TAK1), a downstream signaling player of TNF-┙, coincides with 
the pattern of ROS production, with peak expression also at 3-7 days post-injury (Lam et al, 
2011). Like PPAR┚/├, TAK1 activity is most likely affected by TNF-┙ induction in 
wounding. A known signal transducer in the innate immune response, TAK1 in 
keratinocytes may serve as both an epidermal and an immune factor responsible for the 
pathogenesis of psoriasis. Another separate study reported that mice with an epidermal 
specific deletion of TAK1 suffered massive keratinocyte death attributed to elevated ROS 
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levels which subsequently resulted in severe psoriasiform-like skin inflammation (Omori et 
al, 2008). These findings strongly suggest that the dysregulation of epidermal homeostasis 
could trigger inflammation and initiate/sustain psoriasis of the skin and death by the 7th 
post-natal day (Omori et al, 2008). This precise role of TAK1 in psoriasis needs further 
elucidation.  
To circumvent the limitations of in vivo models, we generated lentiviral-mediated TAK1 
knockdown (TAK1 kd) human keratinocytes and cultured them in organotypic co-cultures 
(OTC). OTC consists of seeded keratinocytes cultured on a dermal-like fibroblast embedded 
collagen layer. The bottom fibroblast/collagen dermal layer contacts the OTC medium, 
while the top keratinocyte layer is exposed to the air. This mimics the in vivo positions of 
keratinocytes and fibroblasts in the intact skin, whereby nutrients are solely supplied to the 
dermis through the dermal blood circulation with nutrients reaching the epidermal layer 
only through diffusion (Stark et al, 2004). The advantage of using OTC models in the study 
of psoriasis is that it allows us to study the behavior and development of keratinocytes at 
the tissue level without the confounding influences of the immune system. This is especially 
useful in psoriasis research so that epidermal factors can be isolated and studied alone, 
without any immune related effects. Using this setup, we found that TAK1 kd OTC 
epidermis displayed significantly higher ROS levels with an increased incidence of 
keratinocyte cell death (Lam et al, 2011). This suggests that TAK1 kd keratinocytes 
succumbed to ROS-induced keratinocyte death even in normal tissue development. A 
unique feature of keratinocytes is that they are naturally subjected to anoikis-induced death 
after detachment from the basement membrane during skin homeostasis. Through flow 
cytometric analyses of DCF and annexin V staining, we found that either TNF-┙ induction 
or anoikis could enhance ROS production and subsequently induce cell death in TAK1 kd 
keratinocytes (Lam et al, 2011). 
Importantly, we found that TAK1 protects healthy keratinocytes from ROS-mediated death 
by inducing epidermal expression of stem cell factor (SCF) through transcription factor c-
Jun. SCF is secreted in an autocrine manner to bind and activate its c-Kit receptor on 
neighboring keratinocytes (Lam et al, 2011). The activation of c-Kit further leads to the 
activation of phosphoinositide-3 kinase (PI3K)/protein kinase B (PKB)┙ to initiate cell 
survival and anti-apoptotic effects (Lam et al, 2011). Incidentally, epidermal deletion of c-
Jun in mice has been shown to produce a realistic psoriatic model (Zenz et al, 2005), further 
substantiating the role of TAK1 in psoriasis pathogenesis. As the skin is frequently exposed 
to oxidative stress from the external environment (Zhou et al, 2009), additional protection of 
keratinocytes is necessary to ensure that epidermal cells do not succumb to a fatal, massive 
cell death fate, similar to mice with epidermal specific TAK 1 deletion (Omori et al, 2008). 
Likewise, the constant microbial insults the skin confronts may lead to inflammatory 
responses like TNF-┙ induction, which will enhance ROS production in keratinocytes 
(Omori et al, 2008). Without the protective effects of TAK1, the epidermis may undergo 
necrotic degeneration especially during episodes of skin infection. We postulate that the 
pathogenesis of psoriasis may involve the suppression of TAK1 mediated protective 
mechanisms against ROS in psoriatic keratinocytes, leading to keratinocyte death and 
inflammation. The degree of this suppression may vary with the severity of psoriasis, with 
mild cases having lower levels of suppression compared to severe cases. Keratinocytes with 
strong suppression would undergo anoikis-triggered ROS elevation and necrotic cell death, 
triggering psoriasis even without any external wounding. Several clinically approved 
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psoriasis drugs have been found to have a therapeutic effect on ROS-induced oxidative 
stress, further favoring the ROS aspect of psoriasis pathogenesis (Zhou et al, 2009). A 
primary example is dimethylfumarate (DMF), which is known to up-regulate glutathione 
(Ghashghaeinia et al, 2010) and the induction of NADPH:quinine oxidoreductase 1 (NQO1) 
(Begleiter et al, 2004), two antioxidative pathways in the cell. Vitamin D analogues also 
increase the production and activity of glucose-6-phosphate dehydrogenase (G6PD), which 
reduces ROS-induced oxidative stress (Bao et al, 2008). 
4. Conclusion 
Chronic psoriasis has a complex pathogenesis, involving both epidermal barrier and 
immune mediated dysfunction. While much of the recent advances have been in the area of 
the immunopathogenesis of psoriasis, the role of epidermal disruption as an initiating event 
and perpetuating cause of psoriasis certainly warrants further investigation and 
understanding. In this chapter, we have highlighted wound healing studies that support the 
key role of epidermal dysfunction in psoriasis and the koebner phenomenon. In particular, 
the role of nuclear receptor S100 proteins and the protective role of TAK1 against ROS 
induced stress were highlighted and discussed. It is noteworthy that the wound healing 
studies using novel organotypic skin cocultures have been crucial in further enhancing our 
understanding of the epidermal dysfunction in psoriasis and complementing existing in vivo 
models. 
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